Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Dueck, AC"" wg kryterium: Autor


Tytuł :
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
Autorzy :
Mascarenhas, J
Kosiorek, H
Prchal, J
Yacoub, A
Berenzon, D
Baer, MR
Ritchie, E
Silver, RT
Kessler, C
Winton, E
Finazzi, MC
Rambaldi, A
Vannucchi, AM
Leibowitz, D
Rondelli, D
Arcasoy, MO
Catchatourian, R
Vadakara, J
Rosti, V
Hexner, E
Kremyanskaya, M
Sandy, L
Tripodi, J
Najfeld, V
Farnoud, N
Salama, ME
Weinberg, RS
Rampal, R
Goldberg, JD
Mesa, R
Dueck, AC
Hoffman, R
Pokaż więcej
Temat :
Article
Źródło :
Leukemia. 33
Tytuł :
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
Autorzy :
Velikova, G
Thanarajasingam, G
Minasian, LM
Baron, F
Cavalli, F
De Claro, RA
Dueck, AC
El-Galaly, TC
Everest, N
Geissler, J
Gisselbrecht, C
Gribben, J
Horowitz, M
Ivy, SP
Jacobson, CA
Keating, A
Kluetz, PG
Krauss, A
Kwong, YL
Little, RF
Mahon, F-X
Matasar, MJ
Mateos, M-V
McCullough, K
Miller, RS
Mohty, M
Moreau, P
Morton, LM
Nagai, S
Rule, S
Sloan, J
Sonneveld, P
Thompson, CA
Tzogani, K
Van Leeuwen, FE
Villa, D
Wingard, JR
Wintrich, S
Seymour, JF
Habermann, TM
Pokaż więcej
Temat :
Hematology [Human health sciences]
Hématologie [Sciences de la santé humaine]
Źródło :
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet. Haematology, 5, 563-598., United KingdomElsevier. (2018).
Opis pliku :
application/pdf
Tytuł :
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
Autorzy :
Velikova, G
Bottomley, A
Pe, M
Sloan, J
Basch, E
Bonnetain, F
Calvert, M
Campbell, A
Cleeland, C
Cocks, K
Collette, L
Dueck, AC
Devlin, N
Flechtner, H-H
Gotay, G
Greimel, E
Griebsch, I
Groenvold, M
Hamel, J-F
King, M
Kluetz, PG
Koller, M
Malone, DC
Martinelli, F
Mitchell, SA
Moinpour, CM
Musoro, J
O'Connor, D
Oliver, K
Piault-Louis, E
Piccart, M
Pimentel, FL
Quinten, C
Reijneveld, JC
Schürmann, C
Smith, AW
Soltys, KM
Taphoorn, MJB
Coens, C
Pokaż więcej
Temat :
no
Źródło :
Lancet Oncology, 17(11), E510 - E514. Lancet Publishing Group
Opis pliku :
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Tytuł :
Impact of software modeling on the accuracy of perfusion MRI in glioma
Autorzy :
Hu, LS
Kelm, Z
Korfiatis, P
Dueck, AC
Elrod, C
Ellingson, BM
Kaufmann, TJ
Eschbacher, JM
Karis, JP
Smith, K
Nakaji, P
Brinkman, D
Pafundi, D
Baxter, LC
Erickson, BJ
Pokaż więcej
Temat :
Models
Magnetic Resonance Imaging
Cerebrovascular Circulation
Neurosciences
Perfusion
Nuclear Medicine & Medical Imaging
Software
Aged
Brain Neoplasms
Middle Aged
circulatory and respiratory physiology
Neurological
Article
Image Interpretation
Computer-Assisted
Glioma
Clinical Sciences
Adult
Female
Humans
Male
Źródło :
Hu, LS; Kelm, Z; Korfiatis, P; Dueck, AC; Elrod, C; Ellingson, BM; et al.(2015). Impact of software modeling on the accuracy of perfusion MRI in glioma. American Journal of Neuroradiology, 36(12), 2242 - 2249. doi: 10.3174/ajnr.A4451. UCLA: Retrieved from: http://www.escholarship.org/uc/item/216339bt
AJNR. American journal of neuroradiology, vol 36, iss 12
Opis pliku :
application/pdf
Tytuł :
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
Autorzy :
Caselli RJ ()
Dueck AC ()
Osborne D ()
Sabbagh MN ()
Connor DJ ()
Ahern GL ()
Baxter LC ()
Rapcsak SZ ()
Shi J ()
Woodruff BK ()
Locke DE ()
Snyder CH ()
Alexander GE ()
Rademakers R ()
Reiman EM ()
Caselli, Richard J ()
Dueck, Amylou C ()
Osborne, David ()
Sabbagh, Marwan N ()
Connor, Donald J ()
Pokaż więcej
Źródło :
New England Journal of Medicine. 7/16/2009, Vol. 361 Issue 3, p255-263. 9p.
Czasopismo naukowe
Tytuł :
Recommendations for including multiple symptoms as endpoints in cancer clinical trials : A report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.
Autorzy :
Cleeland CS
Sloan JA
Cella D
Chen C
Dueck AC
Janjan NA
Liepa AM
Mallick R
O'Mara A
Pearson JD
Torigoe Y
Wang XS
Williams LA
Woodruff JF
Pokaż więcej
Źródło :
Cancer (0008543X); Jan2013, Vol. 119 Issue 2, p411-420, 10p
Czasopismo naukowe
Tytuł :
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.
Autorzy :
Sideras K
Dueck AC
Hobday TJ
Rowland KM Jr
Allred JB
Northfelt DW
Lingle WL
Behrens RJ
Fitch TR
Nikcevich DA
Perez EA
Sideras, Kostandinos
Dueck, Amylou C
Hobday, Timothy J
Rowland, Kendrith M Jr
Allred, Jacob B
Northfelt, Donald W
Lingle, Wilma L
Behrens, Robert J
Fitch, Tom R
Pokaż więcej
Źródło :
Clinical Breast Cancer; 2012 Dec, Vol. 12 Issue 6, p387-391, 5p
Czasopismo naukowe
Tytuł :
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
Autorzy :
Kearns AE
Northfelt DW
Dueck AC
Atherton PJ
Dakhil SR
Rowland KM Jr
Fuloria J
Flynn PJ
Dentchev T
Loprinzi CL
Kearns, Ann E
Northfelt, Donald W
Dueck, Amylou C
Atherton, Pamela J
Dakhil, Shaker R
Rowland, Kendrith M Jr
Fuloria, Jyotsna
Flynn, Patrick J
Dentchev, Todor
Loprinzi, Charles L
Pokaż więcej
Źródło :
Supportive Care in Cancer; Mar2010, Vol. 18 Issue 3, p321-328, 8p
Czasopismo naukowe
Tytuł :
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
Autorzy :
Halyard MY
Pisansky TM
Dueck AC
Suman V
Pierce L
Solin L
Marks L
Davidson N
Martino S
Kaufman P
Kutteh L
Dakhil SR
Perez EA
Halyard, Michele Y
Pisansky, Thomas M
Dueck, Amylou C
Suman, Vera
Pierce, Lori
Solin, Larry
Marks, Larry
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 6/1/2009, Vol. 27 Issue 16, p2638-2644, 7p
Czasopismo naukowe
Tytuł :
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
Autorzy :
Christensen SF; Department of Hematology, Zealand University Hospital, Roskilde, Vestermarksvej 9, 4000, Roskilde, Denmark. .
Scherber RM; Department of Hematology and Oncology, UT Health San Antonio MD Anderson Cancer Center, 7979 Wurzbach Rd, San Antonio, TX, 78229, USA.; Hematologic Malignancies, Incyte Corporation, Wilmington, Delaware, USA.
Mazza GL; Department of Health Sciences Research, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.
Dueck AC; Department of Health Sciences Research, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.
Brochmann N; Department of Hematology, Zealand University Hospital, Roskilde, Vestermarksvej 9, 4000, Roskilde, Denmark.
Andersen CL; Department of Hematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Vestermarksvej 9, 4000, Roskilde, Denmark.
Mesa RA; Department of Hematology and Oncology, UT Health San Antonio MD Anderson Cancer Center, 7979 Wurzbach Rd, San Antonio, TX, 78229, USA.
Geyer HL; Department of Hematology and Medical Oncology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Jun 10; Vol. 21 (1), pp. 691. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Autorzy :
Haddad TC; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. .
He J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
O'Sullivan CC; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Chen B; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Northfelt D; Mayo Clinic, Scottsdale, AZ, USA.
Dueck AC; Mayo Clinic, Scottsdale, AZ, USA.
Ballman KV; Weill Cornell Medical College, New York, NY, USA.
Tenner KS; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Linden H; Seattle Cancer Care Alliance, Seattle, WA, USA.
Sparano JA; Montefiore Medical Center, Bronx, NY, USA.
Hopkins JO; Southeast Clinical Oncology Research (SCOR) Consortium, Winston-Salem, NC, USA.
De Silva C; Kaiser Permanente-Rock Creek, Lafayette, CO, USA.
Perez EA; Mayo Clinic, Jacksonville, FL, USA.
Haluska P; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Goetz MP; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Apr 14. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
Autorzy :
Reni M; Department of Medical Oncology, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy. .
Braverman J; Bristol Myers Squibb, Princeton, NJ, USA.
Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Li CP; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; National Yang-Ming University School of Medicine, Taipei, Taiwan.
Macarulla T; Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, IOB Quirón Barcelona, Barcelona, Spain.
Oh DY; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Riess H; Division of Oncology and Hematology, Charité - Universitätsmedizin, Berlin, Germany.
Tempero M; Division of Hematology and Oncology, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Lu B; Bristol Myers Squibb, Princeton, NJ, USA.
Marcus J; Pharmerit - an OPEN Health Company, Bethesda, MD, USA.
Joshi N; Pharmerit - an OPEN Health Company, Bethesda, MD, USA.
Botteman M; Pharmerit - an OPEN Health Company, Bethesda, MD, USA.
Dueck AC; Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Apr 03. Date of Electronic Publication: 2021 Apr 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Advancing Effective Clinical Trial Designs for Myelofibrosis.
Autorzy :
Kosiorek HE; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Johnson Research Building, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
Dueck AC; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Johnson Research Building, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. Electronic address: dueck..
Pokaż więcej
Źródło :
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2021 Apr; Vol. 35 (2), pp. 431-444.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Benefits of Digital Symptom Monitoring With Patient-Reported Outcomes During Adjuvant Cancer Treatment.
Autorzy :
Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Division of Oncology, University of North Carolina, Chapel Hill, NC.
Leahy AB; Children's Hospital of Philadelphia, PA.
Dueck AC; Mayo Clinic, Scottsdale, AZ.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 01; Vol. 39 (7), pp. 701-703. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
Autorzy :
Wong ML; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Gao J; Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA.
Thanarajasingam G; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Sloan JA; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota, USA.
Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona, USA.
Novotny PJ
Jatoi A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Hurria A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Walter LC; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Miaskowski C; Department of Physiological Nursing, University of California, San Francisco, San Francisco, California, USA.
Cohen HJ; Center for the Study of Aging and Human Development, Duke University, Durham, North Carolina, USA.
Wood WA; Lineberger Comprehensive Cancer Center, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Feliciano JL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Center, Baltimore, Maryland, USA.
Stinchcombe TE; Duke Cancer Institute, Duke University, Durham, North Carolina, USA.
Wang X; Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
The oncologist [Oncologist] 2021 Mar; Vol. 26 (3), pp. e435-e444. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/adverse effects ; Humans ; Paclitaxel/adverse effects
Czasopismo naukowe
Tytuł :
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.
Autorzy :
Tremblay D; Hematology/Oncology Section, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Kosiorek HE; Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, United States.
Dueck AC; Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, United States.
Hoffman R; Hematology/Oncology Section, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Feb 16; Vol. 10, pp. 636675. Date of Electronic Publication: 2021 Feb 16 (Print Publication: 2020).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies